Additional clinical trials are in progress, including the investigation of GLP-1s to treat glaucoma, Friedreich ataxia, and multiple sclerosis
In December, Novo Nordisk (NYSE:NVO) submitted a new drug application to the FDA for a 2.4-mg dose of subcutaneous semaglutide for chronic weight management
Baseline factors including age, hydration habits, fiber intake, existing IBS history, medications (opioids, anticholinergics), and genetic variants in GI peptide pathways all influence susceptibility
They require a specialized, active transport mechanism, scientifically referred to as the "carnitine shuttle," to gain entry into the mitochondrial matrix where they can be burned for fuel
Your vial broke during travel This is why you pack backups
Betacarophylline, a cannabinoid receptor agonist, contributes to pain relief and nerve protection